{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for lasmiditan in Reference URL (approximate match)
Showing 1 - 1 of 1 results
Status:
US Approved Rx
(2019)
Source:
NDA211280
(2019)
Source URL:
First approved in 2019
Source:
NDA211280
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
LASMIDITAN is a serotonin (5-HT) receptor agonist without vasoconstrictor activity, which selectively binds to the 5-HT(1F) receptor subtype. It is under development for the treatment of migraine.
